13N-ammonia
1 paper
- Human trial1
Latest
1 in 12 monthsADA Scientific Sessions 2026 Abstract
Effect of Luseogliflozin on Myocardial Flow Reserve in Patients with Type 2 Diabetes Mellitus (LUCENT-J Study)
Randomised trial in 40 peopleDiabetes mellitus
ADA Scientific Sessions 2025 Abstract
The Significant Reduction in Epicardial Adipose Tissue Thickness after Dapagliflozin Treatment Is Preserved and Even Increased after Four Years—The DAPAHEART Four-Year Follow-up Study
Randomised trial in peopleDapagliflozin